0R0T

Amgen (0R0T)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R0T
DateTimeSourceHeadlineSymbolCompany
09/06/202112:22AMAlliance NewsAmgen, AstraZeneca new asthma drug gets positive phase three results LSE:0R0TAmgen Inc
07/28/20213:59PMAlliance NewsIN BRIEF: Amgen snaps up biologics firm Teneobio for USD900 million LSE:0R0TAmgen Inc
06/23/20215:16AMAlliance NewsAmgen's migraine treatment Aimovig gets approval in Japan LSE:0R0TAmgen Inc
05/28/20213:35PMAlliance NewsAmgen seals US FDA approval for lung cancer treatment LSE:0R0TAmgen Inc
05/13/20213:46AMAlliance NewsAmgen sees "clinically meaningful" results for asthma drug tezepelumab LSE:0R0TAmgen Inc
05/10/202111:24AMAlliance NewsAmgen notes AstraZeneca makes US biologics application for asthma drug LSE:0R0TAmgen Inc
04/27/20213:57PMAlliance NewsTOP NEWS: Amgen first-quarter earnings hurt by Covid-19 LSE:0R0TAmgen Inc
02/26/20218:27AMAlliance NewsAstraZeneca, Amgen Report Positive Tezepelumab Study Results LSE:0R0TAmgen Inc
02/02/20213:57PMAlliance NewsTOP NEWS: Amgen Quarterly Revenue Driven By Otezla, Mvasi Sales LSE:0R0TAmgen Inc
12/22/20203:21PMAlliance NewsAmgen, Astra's Tezepelumab Falls Short Of Primary Endpoint LSE:0R0TAmgen Inc
10/28/20204:09PMAlliance NewsTOP NEWS: Amgen Ups Earnings Guidance As Third-Quarter Revenue Rises LSE:0R0TAmgen Inc
10/08/20208:47AMAlliance NewsAmgen's Omecamtiv Mecarbil Drug Trial Fails To Meet Secondary Endpoint LSE:0R0TAmgen Inc
08/24/202011:31PMAlliance NewsReshuffling The Dow: Exxon, Pfizer Out; Salesforce, Amgen In LSE:0R0TAmgen Inc
07/28/20203:52PMAlliance NewsAmgen Keeps Annual Guidance Despite Fall In Second Quarter Income LSE:0R0TAmgen Inc
06/01/20205:44AMAlliance NewsAlexion And Amgen Come To Soliris Agreement To Avoid US Patent Board LSE:0R0TAmgen Inc
04/01/20202:52AMAlliance NewsAmgen Buys Stake In Japanese Unit; Suspends Enrolment For New Studies LSE:0R0TAmgen Inc
01/31/20204:35AMAlliance NewsAmgen Quarterly Income Hurt By Falling Neulasta Sales LSE:0R0TAmgen Inc
01/02/20209:22AMAlliance NewsAmgen Commences Collaboration With BeiGene To Expand Presence In China LSE:0R0TAmgen Inc
12/12/20196:34AMAlliance NewsEU Approves Amgen Osteoporosis Drug Evenity In Postmenopausal Women LSE:0R0TAmgen Inc
12/09/201912:08PMAlliance NewsAgmen Signs Lease For Research & Development Facility In San Francisco LSE:0R0TAmgen Inc
12/09/20193:58AMAlliance NewsAmgen Gets Regulatory Approval For Arthritis, Crohn's Disease Drug LSE:0R0TAmgen Inc
11/18/20191:00AMAlliance NewsAmgen Reports Positive Analysis Results From Repatha LSE:0R0TAmgen Inc
11/15/201911:42AMAlliance NewsAmgen To Launch Study On PCSK9 Inhibitors Use On Cardiovascular Issues LSE:0R0TAmgen Inc
11/01/20194:20AMAlliance NewsAmgen Acquires 27% Stake In BeiGene, Collaborates On Oncology Pipeline LSE:0R0TAmgen Inc
10/30/20191:00AMAlliance NewsAmgen Boosts Annual Guidance Despite Generics Pressure Hitting Revenue LSE:0R0TAmgen Inc
10/24/20199:30AMAlliance NewsAmgen Removes Original Repatha List Price In Favour Of 60% Lower Price LSE:0R0TAmgen Inc
10/23/201912:59AMAlliance NewsSherwood's President Griffith To Replace Outgoing Amgen's Finance Boss LSE:0R0TAmgen Inc
10/18/20199:00AMAlliance NewsUS FDA Approves Earlier Use Of Amgen Drug In Immune Thrombocytopenia LSE:0R0TAmgen Inc
10/18/201912:44AMAlliance NewsAmgen's Evenity Gets Positive Opinion From European Medicines Agency LSE:0R0TAmgen Inc
09/25/20195:16AMAlliance NewsAmgen Reports "Remarkable" Trial Results For Blincyto Leukemia Drug LSE:0R0TAmgen Inc
 Showing the most relevant articles for your search:LSE:0R0T
Your Recent History
TSX
BCE
BCE Inc
TSX
IVN
Ivanhoe Mi..
FX
CADUSD
Canadian D..
USOTC
XUII
Xumanii In..
FX
EURCAD
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20211028 18:00:34